Regeneron Pharmaceuticals (Nasdaq: REGN) today announced that the European Commission (EC) has granted conditional marketing ...

The USA faces a serious risk of measles becoming endemic again, according to a new study modeling the impact of declining ...

Merck & Co has announced results from the Phase III KEYNOTE-689 trial of Keytruda (pembrolizumab) as a perioperative ...

Hong Kong-based Akeso has announced that the US Food and Drug Administration (FDA) has approved its PD-1 monoclonal antibody, penpulimab-kcqx, alongside cisplatin or carboplatin and gemcitabine, for ...

Shares of French speciality vaccines developer Valneva (Nasdaq: VAL) were down 8.4% at 2.89 euros by early afternoon, after ...

Comac Medical, a full-service contract research organization (CRO) based in Bulgaria, has announced major leadership changes ...

A new category of diabetes, known as type 5 diabetes, has been officially recognized by the International Diabetes Federation ...

After reported discussions since February, German pharma and sciences company Merck KGaA (MRK: DE) has confirmed its ...

USA-based Medicus Pharma (Nasdaq: MDCX) has agreed to acquire UK firm Antev for around $75 million in a share exchange deal.

Belgium’s General Association of the Pharma Industry, known as pharma.de, has emphasized the importance of intellectual ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) late Friday announced it has granted a conditional ...

In one of the largest all-private licensing deals so far this year, worth around 500 million euros ($569 million), ...